Reference number : 236-2018-2019-Q1-00422, amendment number : , agreement type : G, recipient legal name : Fralick, Michael P, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M4N 3M5, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 105000.0, agreement start date : 2018-05-01, agreement end date : 2021-04-30, description english : Using a combined approach of meta-analysis and pharmacoepidemiology to assess the safety of SGLT2 inhibitors (sodium-glucose cotransporter 2), description french : Using a combined approach of meta-analysis and pharmacoepidemiology to assess the safety of SGLT2 inhibitors (sodium-glucose cotransporter 2), expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada